AzTrials
AzTrials

GallstoneNCT06953713

TSH Risk by Extraction Site in Lap Cholecystectomy

A study testing gallbladder extraction umbilical and extracting gallbladder via epigastric port in people with Gallstone, run by Fatih Basak at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The main purpose of this study is to determine whether removing the gallbladder through different incision sites (ports) during laparoscopic surgery affects the risk of developing an incisional hernia. All patients undergo the same number of incisions, and the surgical technique remains standardized. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Gallstone
What is being tested?
gallbladder extraction umbilical and extracting gallbladder via epigastric port
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
110 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Apr 2022to 4 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥ 18 years,
  • Gallbladder stones
  • No known systemic comorbidities (e.g., cardiovascular, pulmonary, metabolic, or immunologic conditions)

Who cannot join

  • Age < 18 years,
  • Open cholecystectomy or conversion from laparoscopy to open surgery,
  • Acute cholecystitis
  • Prior intervention involving the common bile duct,
  • Presence of clinical or radiologic diastasis recti,
  • Presence of clinical or radiologic umbilical hernia.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Umraniye Research and Training Hospital

    Istanbul, Umraniye, 34760

Other trials in Turkey (Türkiye)

About this study

Official title: Umbilical Trochar Site Is The Usual Suspect For Trocar Hernia After Laparoscopic Cholecystectomy: A Prospective Study

The main purpose of this study is to determine whether removing the gallbladder through different incision sites (ports) during laparoscopic surgery affects the risk of developing an incisional hernia. All patients undergo the same number of incisions, and the surgical technique remains standardized.

The study also aims to identify other factors that may contribute to the risk of hernia formation following gallbladder surgery.

Read the detailed description

Patients were blinded to group assignment. Randomization was conducted on the day of surgery by a surgical nurse using the Alea Randomisation mobile application (Alea Clinical Services, Abcoude, Netherlands). Group allocation ("U" for umbilical or "E" for epigastric) was placed in a sealed envelope and delivered to the operating room. The envelope was opened by the attending surgeon immediately prior to gallbladder retrieval.

Due to the nature of the intervention, the operating surgeon could not be blinded; however, surgeons remained unaware of group allocation until the moment of specimen retrieval. All procedures were performed by one of three experienced surgeons.

A conventional four-port laparoscopic cholecystectomy was performed in all cases, using a 10 mm umbilical camera trocar, a 10 mm epigastric trocar, and two 5 mm subcostal trocars. Gallbladder retrieval was performed using a laparoscopic specimen bag through one of the following approaches:

Group U: Gallbladder retrieved through the umbilical trocar

Group E: Gallbladder retrieved through the epigastric trocar

After retrieval and hemostasis, all trocars were removed under direct laparoscopic vision. The umbilical fascia was closed using two interrupted polyglactin 910 sutures (Vicryl, Ethicon Inc., Edinburgh, Scotland), while the epigastric trocar fascia was left unsutured. Fascia closure practices were standardized and unrelated to group allocation. Total operation time and gallbladder retrieval time were recorded.

All patients received paracetamol (Parol, Atabay İlaç, Istanbul, Türkiye) three times daily and tramadol (Contramal, Abdi İbrahim İlaç, Istanbul, Türkiye) twice daily for postoperative pain control. Pain was assessed using the Visual Analogue Scale (VAS) at 6 and 24 hours postoperatively, with the assistance of a ward nurse.

Patients without complications were discharged on postoperative day 1. Those with complications were discharged following resolution of their condition. All patients were followed for one year postoperatively. Patients presenting with hernia-related symptoms (e.g., bulge or pain) underwent ultrasonography (USG) at symptom onset, while asymptomatic patients received routine USG at the six-month and one-year follow-ups. Radiologists performing USGs were not affiliated with the study and were not standardized.

Incisional hernia was defined as a pathological fascial defect at a postoperative trocar site with protrusion of intraabdominal contents. Both clinically and radiologically diagnosed hernias were considered incisional hernias.

Conditions
Gallstone
Being tested
gallbladder extraction umbilical, extracting gallbladder via epigastric port
Keywords
Trocar site hernia, laparoscopic cholecystectomy, incisional hernia, port site hernia
Medical subject headings
Gallstones, Incisional Hernia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • gallbladder extraction umbilicalProcedure or surgery

    extracting gallbladder via umbilical port site

  • extracting gallbladder via epigastric portProcedure or surgery

    extracting gallbladder via epigastric port

Study groups in NCT06953713
Study groupRoleWhat they receive
Umbilical group (Group U)ExperimentalGallbladder retrieved via the umbilical trocar following standard 4-port laparoscopic cholecystectomy
Receives: Procedure: gallbladder extraction umbilical
Epigastric group (Group E)Active comparatorGallbladder retrieved via the epigastric trocar following standard 4-port laparoscopic cholecystectomy
Receives: Procedure: extracting gallbladder via epigastric port

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of Trocar Site Hernia Following Laparoscopic Cholecystectomy

    The primary outcome is to determine whether the site of gallbladder retrieval influences the incidence of postoperative incisional hernia following laparoscopic cholecystectomy.

    Measured: From operation to end of follow-up period at 1 year

Secondary outcomes (2)
  1. Postoperative Pain Assessed by Visual Analog Scale (VAS) at 6 and 24 Hours

    This outcome evaluates the relationship between the gallbladder extraction site and postoperative pain, measured using the Visual Analog Scale (VAS) at 6 and 24 hours after surgery. The VAS is a 10-point scale ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain severity.

    Measured: From end of operation to postoperative 24 hours

  2. Incidence of Trocar Site Hernia in Relation to Patient- and Surgery-Related Risk Factors

    This outcome measures the incidence of trocar site hernia during a one-year follow-up and evaluates its statistical correlation with various clinical and surgical risk factors. These include age (years), sex (male/female), BMI (kg/m²), diabetes status (yes/no), extraction site location (umbilical or epigastric), fascial closure status (closed/open), and intraoperative widening of the extraction site (yes/no). The hernia diagnosis will be based on clinical evaluation and ultrasonographic confirmation.

    Data will be analyzed using correlation or regression methods to assess the strength of association between these variables and hernia development.

    Measured: From operation to end of follow-up period at 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 May 2025
  2. Study start15 Apr 2022
  3. Primary completion15 Jun 2024
  4. Study completion4 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
A standard four-trocar LC was performed using a 10 mm umbilical camera trocar, a 10 mm epigastric trocar, and two 5 mm subcostal trocars. The gallbladder was retrieved using a laparoscopic specimen bag through either: Group U: Gallbladder retrieved via the umbilical trocar, Group E: Gallbladder retrieved via the epigastric trocar.
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
110 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06953713
Sponsor's protocol ID
B.10.1.TKH.4.34.H.GP.0.01/27
Status last verified
Apr 2025
First submitted
7 Apr 2025
Last updated
1 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Raw data, consent forms, CSR, SAP

Publications

  • Sood S, Imsirovic A, Sains P, Singh KK, Sajid MS. Epigastric port retrieval of the gallbladder following laparoscopic cholecystectomy is associated with the reduced risk of port site infection and port site incisional hernia: An updated meta-analysis of randomized controlled trials. Ann Med Surg (Lond). 2020 May 25;55:244-251. doi: 10.1016/j.amsu.2020.05.017. eCollection 2020 Jul.

    PubMed 32528673

Questions about this trial

What is this clinical trial studying?

A study testing gallbladder extraction umbilical and extracting gallbladder via epigastric port in people with Gallstone, run by Fatih Basak at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of Trocar Site Hernia Following Laparoscopic Cholecystectomy (time frame: From operation to end of follow-up period at 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06953713, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in